A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

NCT02040766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

628

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Beclomethasone dipropionate BAI
DRUG: Placebo BAI
DRUG: albuterol/salbutamol 90 mcg
DRUG: Beclomethasone dipropionate MDI
DRUG: Placebo MDI

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.